Galapagos NV (GLPG)

Galapagos NV (GLPG) – FDA

Feb 8, 2023 04:01 PM Galapagos NV (GLPG) announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease
Nov 11, 2022 07:16 AM Galapagos (GLPG) announces CHMP adoption of PRAC’s recommendation for Jyseleca® following extensive safety review of all JAK inhibitors
Oct 3, 2022 04:01 PM
Mar 28, 2022 06:10 AM
Jan 18, 2022 04:03 PM
Nov 15, 2021 10:46 AM
Oct 4, 2021 04:02 PM
Sep 17, 2021 07:17 AM
Jul 14, 2021 04:02 PM
May 27, 2021 04:02 PM
Apr 23, 2021 06:17 AM
Feb 10, 2021 09:01 AM
Dec 15, 2020 04:16 PM
Dec 1, 2020 04:03 PM
Nov 30, 2020 04:03 PM
Oct 15, 2020 04:21 PM
Oct 12, 2020 09:16 AM
Sep 29, 2020 04:11 PM
Sep 25, 2020 01:16 PM
Sep 25, 2020 06:31 AM
Aug 19, 2020 06:11 AM
Aug 19, 2020 06:10 AM
Jul 24, 2020 08:13 AM
Jun 5, 2020 04:02 PM
Jun 4, 2020 06:09 AM
May 20, 2020 04:03 PM
Feb 10, 2020 06:00 AM
Oct 31, 2019 04:46 PM
Oct 11, 2019 06:04 AM
Aug 15, 2019 04:02 PM
Jun 11, 2019 06:10 AM
May 29, 2019 04:34 PM
Apr 23, 2019 04:15 PM
Mar 28, 2019 05:04 PM
Mar 28, 2019 05:03 PM
Jan 7, 2019 06:25 AM
Jan 7, 2019 05:51 AM
Dec 17, 2018 04:24 PM
Nov 27, 2018 04:23 PM
Oct 31, 2018 05:11 PM
Oct 24, 2018 04:53 PM
Oct 22, 2018 01:21 PM
Sep 24, 2018 06:19 AM
Sep 13, 2018 04:06 PM
Sep 12, 2018 04:05 PM
Sep 11, 2018 04:07 PM
Sep 6, 2018 06:00 AM
Jul 9, 2018 05:44 AM
Jun 28, 2018 05:46 PM
Jun 26, 2018 04:03 PM